H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
about
Tackling a novel lethal virus: a focus on H7N9 vaccine development.Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein.Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge.Induction of H7N9-Cross-Reactive Antibody-Dependent Cellular Cytotoxicity Antibodies by Human Seasonal Influenza A Viruses that are Directed Toward the Nucleoprotein.Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans.IRES-based co-expression of influenza virus conserved genes can promote synergistic antiviral effects both in vitro and in vivo.Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.
P2860
Q30148631-D6BA38D4-D719-4A7D-A216-823ADFC9EAC6Q30151807-6524E057-6609-4712-A515-DCBA88A0626FQ30398731-31425C59-08E5-48A3-9246-C5709204702DQ37452408-9F63E482-CFBA-4AE7-9400-AA2394915BD5Q40116170-172B45F5-57A2-43BB-89A2-404C9BD19569Q40397004-FC4FBAD7-61D0-445B-AC8C-E3B033658829Q47137425-87548513-636E-4954-A693-028D889BE75AQ47262061-91EE32ED-22CE-45B6-9BC3-01D2BDF8998AQ55260817-2A9001C9-AFB8-4D5D-A1A4-65792A44CA6C
P2860
H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
H7N9 live attenuated influenza ...... ebo-controlled, phase 1 trial.
@ast
H7N9 live attenuated influenza ...... ebo-controlled, phase 1 trial.
@en
type
label
H7N9 live attenuated influenza ...... ebo-controlled, phase 1 trial.
@ast
H7N9 live attenuated influenza ...... ebo-controlled, phase 1 trial.
@en
prefLabel
H7N9 live attenuated influenza ...... ebo-controlled, phase 1 trial.
@ast
H7N9 live attenuated influenza ...... ebo-controlled, phase 1 trial.
@en
P2093
P2860
P50
P921
P1476
H7N9 live attenuated influenza ...... cebo-controlled, phase 1 trial
@en
P2093
Anatoly Naykhin
Mariana Erofeeva
Marie-Paule Kieny
P2860
P304
P356
10.1016/S1473-3099(15)00378-3
P50
P577
2015-12-08T00:00:00Z